Latest News

AAN DAILY HIGHLIGHTS – WEDNESDAY, APRIL 9, 2025

 

Tuesday Edition
Monday Edition

The following summarizes some of the highlights from Day 3 of the American Academy of Neurology annual meeting (AAN), San Diego, CA, April 5-9, 2025.

MS risk with head trauma
Efficacy of first-line ofatumumab in patients without highly active disease
Semaglutide may reduce MS progression
Higher MS risk with earlier menarche
Biomarker dynamics after DMT initiation
Clinical tip of the day

Read More